Science Explorer Back to mapMap
Discussion
Researcher · Tochigi Cancer Center · Japan

Kokichi Sugano

Kokichi Sugano publishes mostly in Molecular Biology, Pathology and Forensic Medicine and Oncology, on topics such as Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics and BRCA gene mutations in cancer.

ORCID 0000-0001-6729-366X OpenAlex
World rank
#1,998,571
of 7,710,434 ranked researchers
Rank in Japan
#36,298
of 383,136
Works
238
Citations
6k
Citations per work
25.1
h-index
44
i10-index 108Top 5.5% in Molecular Biology
Kokichi Sugano

What does Kokichi Sugano research?

Kokichi Sugano's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (34%).

Health Sciences: 92 works · 38.5% of their workMedicine: 92 works · 38.5% of their workPathology and Forensic Medicine: 37 works · 15.7% of their workOncology: 33 works · 13.8% of their workSurgery: 21 works · 9.0% of their workLife Sciences: 81 works · 34.2% of their workBiochemistry, Genetics and Molecular Biology: 81 works · 34.2% of their workMolecular Biology: 43 works · 17.9% of their workGenetics: 20 works · 8.4% of their workCancer Research: 19 works · 7.9% of their workEverything else: 65 works · 27.3% of their workTHEIR WORKKokichi Sugano238works
Life Sciences34%Health Sciences38%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine9238.5%
    1. Biochemistry, Genetics and Molecular Biology8134.2%
  3. Everything else6527.3%
  1. 1Molecular Biology18% of their works
  2. 2Pathology and Forensic Medicine16% of their works
  3. 3Oncology14% of their works
  4. 4Surgery9% of their works
  5. 5Genetics8% of their works
  6. 6Cancer Research8% of their works

Research topics

Which keywords describe Kokichi Sugano's research?

The keywords of their largest research topics: Cancer Risk, Genetic Testing, Molecular Characterization, Hereditary Syndromes, Microsatellite Instability, Guidelines, Genomic Instability and Cancer Genomics.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Cancer Risk1132 topics
  2. Genetic Testing1132 topics
  3. Molecular Characterization1052 topics
  4. Hereditary Syndromes881 topic
  5. Microsatellite Instability881 topic
  6. Guidelines422 topics
  7. Genomic Instability392 topics
  8. Cancer Genomics291 topic
  9. Mutational Signatures291 topic
  10. BRCA1251 topic
  11. BRCA2251 topic
  12. Colorectal Cancer251 topic
  13. Screening251 topic
  14. DNA Methylation191 topic
  15. Histone Modification191 topic
  16. Bladder Cancer171 topic
  17. Urothelial Carcinoma171 topic
  18. Multiple Primary Cancers161 topic
  19. Second Primary Neoplasms161 topic
  20. DNA Damage101 topic
  21. Repair101 topic

Where does Kokichi Sugano work?

Kokichi Sugano's main affiliation in the publication record is Tochigi Cancer Center, Japan.

How many publications and citations does Kokichi Sugano have?

OpenAlex counts 238 works and 5,970 citations for Kokichi Sugano, an h-index of 44, ranking #1,998,571 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kokichi Sugano. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.